Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selective Bladder Denervation vs Botox for Refractory OAB
NCT06796855Phase 4Completed
- Sponsor
- Bağcılar Training and Research Hospital
- Start
- Feb 2023
- Primary completion
- Feb 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in overactive bladder syndrome (OAB), sponsored by Bağcılar Training and Research Hospital. Primary endpoint: Overactive Bladder Assessment Tool at 12 weeks. Started Feb 2023; status: completed.
02
Conditions
overactive bladder syndrome (OAB)
Beyond the preview
Go deeper on NCT06796855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06796855.